Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Glioblastoma 11Glioma 4Sarcoma, Ewing 2Recurrence 2Medulloblastoma 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Sarcoma 1SCLC, Extensive Stage 1Rhabdomyosarcoma 1Primary Glioblastoma 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Melanoma 1Lymphoma, Follicular 1Hypoxia 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Astrocytoma 1Advanced Glioblastoma 1

Interventions

toripalimab 1tislelizumab 1fluzoparib 1Topotecan 1Temozolomide 1PM 01183 1Etoposide 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × SCLC, Extensive Stage × Temozolomide × Clear all
NCT07141771 2025-08-26

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1/2 Not yet recruiting
100 enrolled
Thoracic

SCLC, Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡